News | November 06, 2024
Venus Remedies gets approval from Malaysian PIC/S GMP for pre-filled syringe facility
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
The inspection concluded with the issuance of a form 483 with five observations
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
The inspection scope included 6 separate Biologics manufacturing units comprising 4 Drug Substance and 2 Drug Product manufacturing plants
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Cellares will dedicate multiple Cell Shuttle and Cell Q systems with fully automated, high-throughput quality control for Bristol Myers Squibb’s exclusive use
Subscribe To Our Newsletter & Stay Updated
